
GC34606
GSK-843
Also known as 3-(1,3-benzothiazol-5-yl)-7-(2,5-dimethylpyrazol-3-yl)thieno[3,2-c]pyridin-4-amine
GSK-843 (GSK'843) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 8·6 nM, and inhibits kinase activity with an IC50 of 6·5 nM
ChemicalCAS1601496-05-2MW377.49FormulaC19H15N5S2
- CAS number
- 1601496-05-2
- Molecular weight
- 377.49
- Formula
- C19H15N5S2
- Solubility
- DMSO : 50 mg/mL (132·45 mM; Need ultrasonic)
- InChIKey
- BPKSNNJTKPIZKR-UHFFFAOYSA-N
- Catalogue number
- GC34606
- Brand
- GLPBIO
Computed properties PubChem CID 91885439 · XLogP 4 · TPSA 126 Ų · H-bond donors 1
- XLogP
- 4
- TPSA
- 126 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 2
- Heavy atoms
- 26
SMILES CC1=NN(C(=C1)C2=CN=C(C3=C2SC=C3C4=CC5=C(C=C4)SC=N5)N)C
Computed descriptors from PubChem (CID 91885439), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il